Medicare Part D spending rose despite prescriptions going down, watchdog says

coapharm2018-06-05T14:27:15+00:00June 5, 2018|

PBMs: Maligned as Middlemen, They’re Hearing Wedding Bells

coapharm2018-06-05T14:25:17+00:00June 5, 2018|

FDA approves Mylan drug as first biosimilar to Amgen’s Neulasta

coapharm2018-06-05T14:24:29+00:00June 5, 2018|

Third Novartis Phase III trial shows Kisqali® combination therapy significantly improves PFS in HR+/HER2- advanced breast cancer

coapharm2018-06-04T20:22:49+00:00June 4, 2018|

New Novartis data presented at ASCO find nearly half of CML patients treated with Tasigna® remain in remission almost three years after stopping therapy

coapharm2018-06-04T20:21:40+00:00June 4, 2018|

Novartis data at ASCO and EHA reinforce company’s commitment to reimagining cancer

coapharm2018-06-04T20:20:30+00:00June 4, 2018|

Mail-order pharmacy system delays meds for some patients

coapharm2018-06-04T13:20:46+00:00June 4, 2018|

Pharmacist says CVS strong-arms cancer-drug business

coapharm2018-06-04T13:19:41+00:00June 4, 2018|

Trump Plan to Lower Drug Prices Could Increase Costs for Some Patients

coapharm2018-06-04T13:18:36+00:00June 4, 2018|

When pharmacy-benefit manager cuts put lives in jeopardy

coapharm2018-06-04T13:12:38+00:00June 4, 2018|